Human secretory phospholipase A₂ mediates decreased plasma levels of HDL cholesterol and ApoA-I in response to inflammation in human ApoA-I transgenic mice

Biochemistry, Genetics and Molecular Biology

• HDL-Cholesterol 100%
• Transgenic Mouse 100%
• Blood Level 100%
• Phospholipase A2 100%
• High-Density Lipoprotein 33%
• Serum Amyloid A 27%
• Blood Plasma 22%
• Lipopolysaccharide 22%
• Phospholipid 16%
• Transgenics 11%
• Mouse Model 5%
• Blood Lipids 5%
• Triglyceride 5%
• Gel Filtration 5%
• Lipoprotein Blood Level 5%
• Acute Phase Protein 5%
• Cholesterol Blood Level 5%
• Acute Phase Response 5%
• Cholesteryl Ester 5%
• Gel Electrophoresis 5%
• Apolipoprotein 5%

Immunology and Microbiology

• Transgenic Mouse 100%
• Blood Level 100%
• High-Density Lipoprotein 100%
• Serum Amyloid A 45%
• Blood Plasma 36%
• Transgenics 18%
• Mouse Model 9%
• Acute Phase Protein 9%
• Lipid Blood Level 9%
• Gene Transfer 9%
• Lipoprotein Blood Level 9%
• Cholesterol Blood Level 9%
• Acute Phase Response 9%
• Gel Filtration 9%
• Apolipoprotein 9%

Neuroscience

• High Density Lipoprotein Cholesterol 100%
• Secretory Phospholipase A2 100%
• Blood Plasma 100%
• High-Density Lipoprotein 33%
• Serum Amyloid A 27%
• Lipopolysaccharide 22%
• Phospholipid 16%
• In Vivo 11%
• Gene Delivery 5%
• Acute Phase Protein 5%
• Gene Transfer 5%
• Cholesterol Ester 5%
• Triacylglycerol 5%
• Apolipoprotein A 5%
• Gel Electrophoresis 5%